Form 8-K Perspective Therapeutics For: Oct 23
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St eyes best day in a month as Anthropic's IPO filing propels AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Brazilās Lula wins historic fourth term, Flavio Bolsonaro refuses to concede
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Borr Drilling rig sinks off Gabon, one person dead and four missing
- Britain will not join Canada-led defence bank initiativeĀ
- CAE agrees to sell Flightscape unit to SITA for $500 million
BTIG on Perspective Therapeutics Inc (CATX): 'would be buyers on weakness'
October 26, 2026 5:13 AM EDTBTIG analyst Jeet Mukherjee reiterated a Buy rating and $14.00 price target on Perspective Therapeutics Inc (NYSE: CATX).
The analyst comments "CATX presented its largest and longest follow-up VMT-- NET dataset to date at ESMO, with the full cohort 2 now in and the first look at cohort... More



